TradeLink Capital’s Elevance Health ELV Stock Holding History

TradeLink Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-400	Closed	-$217K	–	32
2024 Q2	$217K	Buy	+400	New	+$211K	0.63%	75
2016 Q2	–	Sell	-1,828	Closed	-$254K	–	108
2016 Q1	$254K	Buy	1,828 +55	+3%	+$7.35K	0.47%	79
2015 Q4	$247K	Buy	+1,773	New	+$244K	0.51%	61
2015 Q2	–	Sell	-1,790	Closed	-$276K	–	152
2015 Q1	$276K	Sell	1,790 -510	-22%	-$72.6K	0.7%	29
2014 Q4	$289K	Hold	2,300	–	–	0.38%	45
2014 Q3	$275K	Hold	2,300	–	–	0.44%	30
2014 Q2	$248K	Hold	2,300	–	–	0.23%	110
2014 Q1	$229K	Hold	2,300	–	–	0.33%	84
2013 Q4	$212K	Hold	2,300	–	–	0.28%	137
2013 Q3	$192K	Sell	2,300 -1,000	-30%	-$85.7K	0.44%	113
2013 Q2	$270K	Buy	+3,300	New	+$247K	0.08%	229

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

TradeLink Capital's ELV Position: Q3 2024 in Review

TradeLink Capital sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 400 shares — an estimated $217K sold.

TradeLink Capital first reported a position in ELV in Q2 2013 and held it in 11 quarters. The position peaked at $289K in Q4 2014. 1,698 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

TradeLink Capital reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
TradeLink Capital sold 400 Elevance Health shares in Q3 2024, an estimated $217K.
TradeLink Capital first reported a position in Elevance Health in Q2 2013 and held it in 11 quarters.
TradeLink Capital's Elevance Health position peaked at $289K in Q4 2014.
1,698 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on TradeLink Capital's 13F filing for Q3 2024, filed 12 Nov 2024.